Hyoscyamine sulfate 0.025 MG/ML Oral Solution — RxCUI 1047881
RxNorm drug concept · Semantic clinical drug
RxCUI 1047881
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1047881
Official nameHyoscyamine sulfate 0.025 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashyoscyamine sulfate 0.125 MG per 5 ML Oral Solution; hyoscyamine sulfate 0.125 MG in 5 mL Oral Solution
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)549 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hyoscyamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
📖 Read our full Hyoscyamine guide →
🕸️ Concept Web — How Hyoscyamine sulfate 0.025 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hyoscyamine sulfate 0.025 MG/ML Oral Solution
RxCUI 1047881 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hyoscyamine
153970IN -
Hyoscyamine sulfate
1225PIN
-
Hyoscyamine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hyoscyamine Oral Solution
372445SCDF -
Hyoscyamine sulfate Oral Solution
2649425SCDFP -
Hyoscyamine Oral Liquid Product
1165277SCDG -
Hyoscyamine Oral Product
1165278SCDG -
Hyoscyamine sulfate Oral Liquid Product
2660739SCDGP -
Hyoscyamine sulfate Oral Product
2659505SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Hyoscyamine Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hyoscyamine sulfate 0.025 MG/ML
1047880SCDC
-
Hyoscyamine sulfate 0.025 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hyoscyamine sulfate 0.025 MG/ML
SCDC · 1047880 -
Hyoscyamine Oral Solution
SCDF · 372445 -
Hyoscyamine sulfate Oral Solution
SCDFP · 2649425 -
Hyoscyamine Oral Liquid Product
SCDG · 1165277 -
Hyoscyamine Oral Product
SCDG · 1165278 -
Hyoscyamine sulfate Oral Liquid Product
SCDGP · 2660739 -
Hyoscyamine sulfate Oral Product
SCDGP · 2659505
📦 FDA Products & Package NDCs
8 products · 8 package NDCs
8 package NDCs map to RxCUI 1047881 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 17856-0511-02 | 72 CUP in 1 BOX (17856-0511-2) / 10 mL in 1 CUP | Hyosyne | ATLANTIC BIOLOGICALS CORP. | 2024-04-10 |
| 17856-0514-05 | 5 mL in 1 CUP (17856-0514-5) | Hyosyne | ATLANTIC BIOLOGICALS CORP. | 2024-04-12 |
| 54838-0511-80 | 473 mL in 1 BOTTLE, PLASTIC (54838-511-80) | Hyosyne | Lannett Company, Inc. | 1997-11-01 |
| 62135-0511-47 | 473 mL in 1 BOTTLE (62135-511-47) | Hyoscyamine Sulfate | Chartwell RX, LLC | 2022-07-20 |
| 62135-0512-12 | 120 TABLET in 1 BOTTLE (62135-512-12) | Hyoscyamine sulfate | Chartwell RX, LLC | 2022-11-17 |
| 62135-0513-52 | 20 mL in 1 BOTTLE (62135-513-52) | Hyoscyamine sulfate | Chartwell RX, LLC | 2022-08-01 |
| 62135-0858-12 | 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-858-12) | Hyoscyamine sulfate | Chartwell RX, LLC | 2024-09-20 |
| 62135-0859-12 | 120 TABLET in 1 BOTTLE (62135-859-12) | Hyoscyamine sulfate Sublingual | Chartwell RX, LLC | 2024-09-20 |
Observed labelers:
Chartwell RX, LLC (5) ·
ATLANTIC BIOLOGICALS CORP. (2) ·
Lannett Company, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.